Article Contents ::
- 1 The Brand Name OVURELIX Has Generic Salt :: CETRORELIX
- 2 OVURELIX Is From Company SUN Priced :: Rs. 880
- 3 OVURELIX have CETRORELIX is comes under Sub class #N/A of Main Class #N/A
- 4 Main Medicine Class:: #N/A Sub Medicine Class :: #N/A
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
The Brand Name OVURELIX Has Generic Salt :: CETRORELIX
OVURELIX Is From Company SUN Priced :: Rs. 880
OVURELIX have CETRORELIX is comes under Sub class #N/A of Main Class #N/A
Main Medicine Class:: #N/A Sub Medicine Class :: #N/A
| Salt Name : OR Generic Name | Form | Price : MRP /Probable | Packing | ||
| CETRORELIX | INJ | Rs. 880 | 2ML V. |
| Brand Name | Company / Manufacturers | Strength | Unit | Price / 2ML V. |
| OVURELIX | SUN | 0.25MG | 2ML V. | Rs. 880 |
| Company Brand Name | Salt Combination | Main Medical Class | Sub Medical Class |
| From SUN :: OVURELIX | CETRORELIX | #N/A | #N/A |
Indications for Drugs ::
Assisted reproductive technologies, In-vitro fertilization
Drug Dose ::
Adult: SC 250 mcg/day, given either in the morning beginning on the day 5 or 6 of ovarian stimulation or in the evening beginning on day 5, and continued until ovulation induction.
Contraindication ::
Hypersensitivity. Moderate to severe renal or hepatic impairment. Women with severe allergic conditions. Pregnancy and lactation;
Drug Precautions ::
Women with active allergic conditions or a history of allergies; childn; elderly >65 yrs
Drug Side Effects ::
Mild and transient reactions at Inj site, nausea, headache, ovarian hyperstimulation syndrome, systemic hypersensitivity reactions.
Pregnancy category ::
5
Drug Mode of Action ::
Cetrorelix, a synthetic decapeptide analog of naturally occurring gonadorelin, is a gonadorelin antagonist. It competitively blocks gonadorelin receptors on the anterior piyuitary gonadotroph and the subsequent transduction pathway, inducing a rapid, reversible suppression of gonadotrophin secretion.
Drug Interactions ::
In vitro investigations have shown that interactions are unlikely with medications that are metabolised by cytochrome P-450 or glucuronised or conjugated in some other way. However, the possibility of interactions with commonly used medicinal products can not entirely be excluded.
